Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Hepatology. 2016 Mar 31;63(6):1977–1986. doi: 10.1002/hep.28499

Table 3.

Comparison of the clinical features among three subjects with NCPH in the absence of liver synthetic dysfunction and who harbor a recurrent recessive p.N46S mutation in DGUOK, and patients suffering from mtDNA depletion syndrome 3 (OMIM#251880) due to DGUOK deficiency.

Patient 1 Patient 2A Patient 2B mtDNA depletion syndrome 3 (hepatocerebral type)*
Age at Presentation 12 yo 5 m 5 yo infancy and early childhood
AST / ALT WNL WNL to 8x ULN WNL WNL to 20x ULN
Conjugated hyperbilirrubinemia +
Coagulopathy +
Cirrhosis / Liver failure +
Portal hypertension findings in the absence of cirrhosis or liver failure +1 +2 +3
Neurological impairment +
Follow-up Time /Prognosis 6 y / stable with no liver or neurological dysfunction 16 y / stable with no liver or neurological dysfunction 6 y / stable with no liver or neurological dysfunction N/A / poor prognosis due to progressive liver +/− neurological dysfunction

yo, years old; m, months; y, years; N/A, not applicable; WNL, within normal limit; ULN, upper limit of normal; +, present; -, absent. Phenotypic differences between the patients in our study with N46S recessive DGUOK mutation and the subjects with mtDNA depletion syndrome 3 (hepatocerebral type) associated with DGUOK deficiency are depicted by gray shading.

*

Phenotype OMIM number 251880.

1

Splenomegaly and small non-bleeding esophageal varices.

2

Splenomegaly and large non-bleeding esophageal varices.

3

Splenomegaly.